日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo)

一项多中心随机 II 期试验,比较乐伐替尼联合依维莫司与卡博替尼治疗 PD-1 免疫检查点抑制剂治疗后进展的转移性透明细胞肾细胞癌患者的疗效(LenCabo)

Hahn, A W; Chahoud, J; Skelton, W P; Yuan, Y; Zurita-Saavedra, A J; Kovitz, C; Alhalabi, O; Campbell, M T; Jonasch, E; Lin, J K; Desai, M; Santos, M J M N; Hwang, H; Corn, P G; Msaouel, P; Tannir, N M

Influence of body composition on the efficacy of nivolumab plus ipilimumab for metastatic clear cell renal cell carcinoma

体成分对纳武利尤单抗联合伊匹木单抗治疗转移性透明细胞肾细胞癌疗效的影响

Grewal, Kabir; Moura Nascimento Santos, Maria Julia; Chauhan, Pankaj Kumar; Yu, Kai; Tannir, Nizar M; Mukhida, Sagar S; Venkatesh, Neha; Shah, Amishi Y; Zurita, Amado J; Johns, Andrew C; Campbell, Matthew T; Goswami, Sangeeta; Gao, Jianjun; Jonasch, Eric; McQuade, Jennifer L; Alhalabi, Omar; Msaouel, Pavlos; Hahn, Andrew W

Control arm overperformance in phase 3 oncology clinical trials

对照组在3期肿瘤临床试验中表现优于对照组

Nalin, Ansel P; Msaouel, Pavlos; Grippin, Adam J; Kouzy, Ramez; Abi Jaoude, Joseph; Lin, Timothy A; Miller, Avital M; Meimoun, Noah S; Ludmir, Ethan B; Sherry, Alexander D

Random Assignment, But Without Comparison: A Missed Opportunity

随机分配,但缺乏比较:错失良机

Sherry, Alexander D; Ludmir, Ethan B; Msaouel, Pavlos

Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma

肾细胞癌对免疫检查点抑制剂的异常反应的免疫基因组学决定因素

Jammihal, Tejas; Saliby, Renee Maria; Labaki, Chris; Soulati, Hanna; Gallegos, Juan; Peris, Arnau; McCurry, Dustin; Yu, Chunlei; Shah, Valisha; Poduval, Deepak; El Zarif, Talal; El Ahmar, Nourhan; Laimon, Yasmin Nabil; Eid, Marc; Sheshdeh, Aseman Bagheri; Krajewski, Katherine M; Büttner, Florian A; Schwab, Matthias; Heng, Daniel; Casellas, Rafael C; Rai, Kunal; Zacharias Millward, Niki M; Msaouel, Pavlos; Karam, Jose; Signoretti, Sabina; Van Allen, Eliezer; Choueiri, Toni K; Braun, David A; Shukla, Sachet A

Sickle cell disease induces chromatin introversion and ferroptosis in CD8+ T cells to suppress anti-tumor immunity

镰状细胞病诱导CD8+ T细胞染色质内翻和铁死亡,从而抑制抗肿瘤免疫。

Zilong Zhao ,Benxia Hu ,Yalan Deng ,Melinda Soeung ,Jun Yao ,Lanxin Bei ,Yaohua Zhang ,Pengju Gong ,Lisa A Huang ,Zhou Jiang ,Jian Gao ,Shuang Peng ,Tina K Nguyen ,Menuka Karki ,Bora Lim ,Cassian Yee ,Jared K Burks ,Qing Zhang ,Li Ma ,Jianjun Gao ,Nizar M Tannir ,Leng Han ,Dihua Yu ,Linghua Wang ,Michael A Curran ,Maria A Gubbiotti ,Giannicola Genovese ,Boyi Gan ,Wenbo Li ,Pavlos Msaouel ,Liuqing Yang ,Chunru Lin

Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis

现代 III 期肿瘤临床试验中总生存期和生活质量优势:一项荟萃流行病学分析

Sherry, Alexander D; Miller, Avital M; Parlapalli, Jnana Preeti; Kupferman, Gabrielle S; Beck, Esther J; McDonald, Jordan; Kouzy, Ramez; Abi Jaoude, Joseph; Lin, Timothy A; Sanford, Nina N; Chino, Fumiko; Gyawali, Bishal; Booth, Christopher; Msaouel, Pavlos; Ludmir, Ethan B

Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.

纳武利尤单抗联合伊匹木单抗可诱导肾髓质癌超进展:II期试验结果和临床前证据。

Soeung Melinda, Yan Xinmiao, Zanca Ciro, Qian Jing, Karki Menuka, Duan Fei, Khan Hania, Zhang Li, Peng David H, Williams Mariah, He Rong, Chen Ziheng, Perelli Luigi, Chen Jianfeng, Tidwell Rebecca S, Chauhan Pankaj K, Le Courtney N, Lam Truong N A, Bhattacharya Nirjar, Shah Rutvi, Ho I-Lin, Gay Jason P, Carrillo Caroline C, Feng Ningping, Le Kang, Gao Guang, Perry Teresa L, Mseeh Faika, Jiang Yongying, Xu Quanyun A, Zacharias Niki Marie, Sheth Rahul A, Bathala Tharakeswara K, Rao Priya, Daw Najat C, Tripathi Durga N, Walker Cheryl L, Mohammad Mohammad M, Zhang Jianhua, Han Guangchun, Chu Yanshuo, Wang Ruiping, Dang Minghao, Dai Enyu, Peng Fuduan, Liu Yunhe, Jadhav Akshaya, Lang Wenhua, Arrechedera Claudio A, Clemente Leticia Campos, Parra Edwin R, Lu Hsinyi, Haymaker Cara L, Wistuba Ignacio I, Futreal Andrew, Viale Andrea, Soth Michael J, Jones Philip, Marszalek Joseph R, Heffernan Timothy, Draetta Giulio F, Tannir Nizar M, Gao Jianjun, Wang Linghua, Genovese Giannicola, Msaouel Pavlos

Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling

通过整合基因组和转录组分析鉴定肾髓质癌的治疗靶点

Pavlos Msaouel,Nizar M Tannir,Funda Meric-Bernstam,Jennifer M King,Martin H Voss,Jessica P Cheng,Susan S Thomas,Zita D Lim,Menuka Karki,Rong He,Giannicola Genovese,Rahul A Sheth,Davis R Ingram,Diana Shamsutdinova,Khalida M Wani,Wei-Lien Wang,Alexander J Lazar,Dominique Knipper-Davis,Amber Berlinski,Tayla Soares,Danil Stupichev,Kirill Kryukov,Suren Davitavyan,Anna Novokreshchenova,Dmitry Lebedev,Stanislav Kurpe,Andrey Kravets,Dmitrii Belousov,Michael Hensley,Alexander Bagaev,Francesca Paradiso,Vladimir Kushnarev

Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma

纳武利尤单抗联合伊匹木单抗治疗转移性变异型(非透明细胞)肾细胞癌患者的疗效和安全性

Moussa, Mohammad Jad; Khandelwal, Jaanki; Wilson, Nathaniel R; Malikayil, Kiran L; Surasi, Devaki Shilpa; Bathala, Tharakeswara K; Lin, Yiyun; Rao, Priya; Tamboli, Pheroze; Sircar, Kanishka; Ajufo, Helen; Elsayes, Khaled M; Shah, Amishi; Johns, Andrew C; Goswami, Sangeeta; Hasanov, Elshad; Jonasch, Eric; Msaouel, Pavlos; Campbell, Matthew T; Alhalabi, Omar; Tannir, Nizar M